Company Directory / Pharmaceuticals
ClosedFor profitPharmaceuticalsUnited Kingdom
CellZome
CellZome is a pharmaceutical company that discovers, develops, and commercializes kinase-targeted drugs.
- Founded
- 2000 26 years ago
- Staff
- 51-100 37 on LinkedIn
- Followers
- 2k on LinkedIn
- Funding
- $69M as listed, USD
Cellzome is a privately-owned drug discovery company identifying a new generation of kinase- targeted drugs to treat inflammatory diseases. Its pipeline of small-molecule therapeutics is driven by Kinobeads™, a proprietary technology for the screening and profiling of kinases in relevant cells and tissues. Cellzome is applying its distinctive Kinobeads™ technology to the discovery and development of novel, selective, kinase inhibitors targeting key inflammatory mediators in immune receptor signalling and… Read all
Cellzome is a privately-owned drug discovery company identifying a new generation of kinase- targeted drugs to treat inflammatory diseases. Its pipeline of small-molecule therapeutics is driven by Kinobeads™, a proprietary technology for the screening and profiling of kinases in relevant cells and tissues. Cellzome is applying its distinctive Kinobeads™ technology to the discovery and development of novel, selective, kinase inhibitors targeting key inflammatory mediators in immune receptor signalling and chemotaxis, including PI3Kγ and Zap-70.
Set against six million companies
Size
51-100 people: larger than 75% of companies with a size listed. 37 people list it on LinkedIn.
Age
26 years old.
Reach
No web traffic ranking listed. 1,701 followers on LinkedIn.
What it does
BiotechnologyMedicalPharmaceuticalTherapeuticsproteomicsdrug discoveryinflammation
Funding, as listed
$69M raised in total
- Rounds4
- LatestGrant, Nov 2008
- Latest amountUSD 5,006,404
- Investors10, 2 leading
What the source datasets report. We have not watched these rounds ourselves, and do not hold this company in the startups database.
Every detail we hold
Everything the source datasets list about CellZome, field by field. Contact details are held but never shown.
The company
- Name
- CellZome
- Type
- For profit
- Status
- Closed
- Founded
- 2000
- Founders
- Bernard Gilly, Stelios Papadopoulos
- Industry
- Pharmaceuticals
- Categories
- Biotechnology, Medical, Pharmaceutical, Therapeutics
- Specialities
- proteomics, drug discovery, inflammation
Where
- Country
- United Kingdom
- Markets
- European Union (EU), Europe, Middle East, and Africa (EMEA)
Size and reach
- Staff band
- 51-100
- People on LinkedIn
- 37
- LinkedIn followers
- 1,701
Funding, as listed
- Total
- $69,288,841 USD
- Rounds
- 4
- Latest round
- Grant
- Latest round date
- Nov 2008
- Latest amount
- 5,006,404 USD
- Investors
- 10
- Lead investors
- 2
- Listing status
- private
About this record
- Sources
- Crunchbase, LinkedIn
- Last imported
- Sept 2026
Companies like it
Pharmaceuticals in United Kingdom.
Ferring Controlled TherapeuticsEast Kilbride · 5001-10000 people · 1k followers
Oxford BioMedicaOxford · 501-1000 people · 47k followers
Redx PharmaAlderley Park · 51-100 people · 12k followers
Archimedes PharmaReading · 51-100 people · 4k followers
EUSA PharmaHemel Hempstead · 51-100 people · 14k followersFrom the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 372,993 companies in United Kingdom and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.